Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-053725
Filing Date
2021-08-27
Accepted
2021-08-27 18:48:06
Documents
2
Period of Report
2021-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1544
2 POA DOCUMENT poa.txt EX-24.3_1006119 4679
  Complete submission text file 0001209191-21-053725.txt   7656
Mailing Address 2735 SAND HILL ROAD MENLO PARK CA 94025
Business Address
ROOT JONATHAN D (Reporting) CIK: 0001225480 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39866 | Film No.: 211220472

Mailing Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 51ST FLOOR BOSTON MA 02116 2157319450
eFFECTOR Therapeutics, Inc. (Issuer) CIK: 0001828522 (see all company filings)

EIN.: 853306396 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations